Skip to main content

CANCER DRUGS FUND AND NHS COMMISSIONING BOARD

EDM (Early Day Motion) 1251: tabled on 26 March 2013

Tabled in the 2012-13 session.

This motion has been signed by 19 Members. It has not yet had any amendments submitted.

As this motion is using historical data, we may not have the record of the original ordering, in which case signatories are listed alphabetically.

Motion text

That this House is aware that the Department of Health will shortly transfer responsibility for the Cancer Drugs Fund to the NHS Commissioning Board, causing authority for decisions on which drugs and treatments are reimbursed to move from a regional to a national level; understands that a national list of approved drugs and treatments has now been drawn up by the new authority, which excludes a number of drugs and treatments currently approved in some regions; is alarmed therefore that such a transition of responsibility has already caused some patients not to have access to the drugs or therapies they need; and calls on the Government to fulfil its earlier pledges that this organisational change would not cause such an outcome but instead better facilitate sufferers' access to the treatments they need.

The first 6 Members who have signed to support the motion are the sponsors. The primary sponsor is generally the person who tabled the motion and has responsibility for it. The date shown is when the Member signed the motion.

In addition to the sponsors, the following Members have signed to support the motion.

There are no withdrawn signatures for this motion.